Goldman Sachs Gives Chemours Company (CC) Lower Rating. Buy Rating Lost; Shorts at ANTA SPORTS PRODUCTS LTD (ANPDF) Lowered By 0.79%

December 6, 2017 - By Dolores Ford

Among 8 analysts covering Chemours (NYSE:CC), 6 have Buy rating, 0 Sell and 2 Hold. Therefore 75% are positive. Chemours has $60.0 highest and $5.25 lowest target. $49.67’s average target is 7.95% above

currents $46.0108 stock price. Chemours had 32 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Neutral” rating by UBS given on Monday, August 7. UBS maintained it with “Neutral” rating and $59 target in Friday, November 3 report. Jefferies maintained The Chemours Company (NYSE:CC) rating on Tuesday, October 10. Jefferies has “Buy” rating and $60.0 target. The firm has “Buy” rating given on Wednesday, August 10 by Argus Research. The rating was initiated by Argus Research on Friday, September 18 with “Hold”. The firm has “Overweight” rating given on Monday, November 6 by Barclays Capital. Jefferies maintained The Chemours Company (NYSE:CC) rating on Friday, June 16. Jefferies has “Buy” rating and $48 target. Citigroup upgraded The Chemours Company (NYSE:CC) on Wednesday, July 5 to “Buy” rating. Jefferies upgraded The Chemours Company (NYSE:CC) on Wednesday, March 29 to “Buy” rating. The firm has “Hold” rating by Jefferies given on Tuesday, February 16.

ANTA SPORTS PRODUCTS LTD (OTCMKTS:ANPDF) had a decrease of 0.79% in short interest. ANPDF’s SI was 1.01M shares in December as released by FINRA. Its down 0.79% from 1.02M shares previously. With 500 avg volume, 2018 days are for ANTA SPORTS PRODUCTS LTD (OTCMKTS:ANPDF)’s short sellers to cover ANPDF’s short positions. It closed at $4.4 lastly. It is down 0.00% since December 6, 2016 and is . It has underperformed by 16.70% the S&P500.

The stock decreased 6.67% or $3.2892 during the last trading session, reaching $46.0108. About 4.22 million shares traded or 74.27% up from the average. The Chemours Company (NYSE:CC) has risen 327.71% since December 6, 2016 and is uptrending. It has outperformed by 311.01% the S&P500.

Analysts await The Chemours Company (NYSE:CC) to report earnings on February, 21. They expect $0.99 EPS, up 1,137.50% or $0.91 from last year’s $0.08 per share. CC’s profit will be $183.30 million for 11.62 P/E if the $0.99 EPS becomes a reality. After $1.12 actual EPS reported by The Chemours Company for the previous quarter, Wall Street now forecasts -11.61% negative EPS growth.

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company has market cap of $8.52 billion. It operates through three divisions: Titanium Technologies, Fluoroproducts, and Chemical Solutions. It has a 30.23 P/E ratio. The Titanium Technologies segment makes and sells titanium dioxide under the Ti-Pure brand name to deliver whiteness, brightness, opacity, and protection in various applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, PVC window profiles, laminate papers, and coated papers and paperboards used for packaging.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>